| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2850660 | American Heart Journal | 2012 | 8 Pages |
Abstract
Among high-risk patients with STEMI undergoing early or late transfer for cardiac catheterization after fibrinolysis, enoxaparin was associated with similar efficacy compared with UFH, but there was more minor bleeding with enoxaparin (ClinicalTrials.gov no. NCT00164190).
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shahar MD, Warren J. MD, Amparo MD, PhD, Mary K. MSc, Andrew T. MD, VladimÃr MD, David MD, Eric A. MD, Bjug MD, Michael MD, John MD, Shaun G. MD, MSc,